Effective induction of anti-tumor immunity using p5 HER-2/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN.

MLA

Mansourian, Mercedeh, et al. “Effective Induction of Anti-Tumor Immunity Using P5 HER-2/Neu Derived Peptide Encapsulated in Fusogenic DOTAP Cationic Liposomes Co-Administrated with CpG-ODN.” Immunology Letters, vol. 162, no. 1 Pt A, Nov. 2014, pp. 87–93. EBSCOhost, https://doi.org/10.1016/j.imlet.2014.07.008.

APA

Mansourian, M., Badiee, A., Jalali, S. A., Shariat, S., Yazdani, M., Amin, M., & Jaafari, M. R. (2014). Effective induction of anti-tumor immunity using p5 HER-2/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN. Immunology Letters, 162(1 Pt A), 87–93. https://doi.org/10.1016/j.imlet.2014.07.008

Chicago

Mansourian, Mercedeh, Ali Badiee, Seyed Amir Jalali, Sheida Shariat, Mona Yazdani, Mohamdreza Amin, and Mahmoud Reza Jaafari. 2014. “Effective Induction of Anti-Tumor Immunity Using P5 HER-2/Neu Derived Peptide Encapsulated in Fusogenic DOTAP Cationic Liposomes Co-Administrated with CpG-ODN.” Immunology Letters 162 (1 Pt A): 87–93. doi:10.1016/j.imlet.2014.07.008.